| Drug Type Recombinant polypeptide | 
| Synonyms NU 206, NU-206, NU206 + [2] | 
| Target | 
| Action modulators | 
| Mechanism DKK1 modulators(Dickkopf-related protein 1 modulators) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization | 
| Drug Highest PhaseDiscontinuedPhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Bone Diseases | Phase 1 | China  | - | |
| Bone Diseases | Phase 1 | Australia  | - | - | 
| Bone Diseases | Phase 1 | - | - | |
| Inflammatory Bowel Diseases | Phase 1 | China  | - | |
| Inflammatory Bowel Diseases | Phase 1 | Australia  | - | - | 
| Inflammatory Bowel Diseases | Phase 1 | - | - | |
| Mucositis | Phase 1 | China  | - | |
| Mucositis | Phase 1 | Australia  | - | - | 
| Mucositis | Phase 1 | - | - | |
| Wounds and Injuries | Phase 1 | Australia  | - | - | 






